172 related articles for article (PubMed ID: 33586514)
1. Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers.
Lopata E; Terrone C; Gopalan A; Ladikos N; Richardson T
J Manag Care Spec Pharm; 2021 Jun; 27(6):706-713. PubMed ID: 33586514
[No Abstract] [Full Text] [Related]
2. Opportunities and challenges surrounding financial models for high-investment medications: A survey of access decision-makers and employers.
Lopata E; Terrone C; Gopalan A
J Manag Care Spec Pharm; 2023 Jul; 29(7):782-790. PubMed ID: 37133434
[No Abstract] [Full Text] [Related]
3. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
[TBL] [Abstract][Full Text] [Related]
4. AMCP Partnership Forum: Designing Benefits and Payment Models for Innovative High-Investment Medications.
J Manag Care Spec Pharm; 2019 Feb; 25(2):156-162. PubMed ID: 30698091
[TBL] [Abstract][Full Text] [Related]
5. The Current Status of Outcomes-Based Contracting for Manufacturers and Payers: An AMCP Membership Survey.
Duhig AM; Saha S; Smith S; Kaufman S; Hughes J
J Manag Care Spec Pharm; 2018 May; 24(5):410-415. PubMed ID: 29337604
[TBL] [Abstract][Full Text] [Related]
6. Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs.
Yeung K; Suh K; Basu A; Garrison LP; Bansal A; Carlson JJ
J Manag Care Spec Pharm; 2017 Oct; 23(10):1084-1090. PubMed ID: 28944726
[TBL] [Abstract][Full Text] [Related]
7. AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection.
J Manag Care Spec Pharm; 2020 Jan; 26(1):55-62. PubMed ID: 31880226
[TBL] [Abstract][Full Text] [Related]
8. An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plans.
Robinson SW; Brantley K; Liow C; Teagarden JR
J Manag Care Spec Pharm; 2014 Oct; 20(10):997-1004. PubMed ID: 25278322
[TBL] [Abstract][Full Text] [Related]
9. AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.
J Manag Care Spec Pharm; 2016 Jul; 22(7):826-31. PubMed ID: 27333323
[TBL] [Abstract][Full Text] [Related]
10. AMCP Partnership Forum: Advancing Value-Based Contracting.
J Manag Care Spec Pharm; 2017 Nov; 23(11):1096-1102. PubMed ID: 29083973
[TBL] [Abstract][Full Text] [Related]
11. Strategies for Overcoming Barriers to Adopting Biosimilars and Achieving Goals of the Biologics Price Competition and Innovation Act: A Survey of Managed Care and Specialty Pharmacy Professionals.
Greene L; Singh RM; Carden MJ; Pardo CO; Lichtenstein GR
J Manag Care Spec Pharm; 2019 Aug; 25(8):904-912. PubMed ID: 31007119
[TBL] [Abstract][Full Text] [Related]
12. Affordability Challenges to Value-Based Pricing: Mass Diseases, Orphan Diseases, and Cures.
Danzon PM
Value Health; 2018 Mar; 21(3):252-257. PubMed ID: 29566830
[TBL] [Abstract][Full Text] [Related]
13. AMCP Partnership Forum: Driving Value and Outcomes in Oncology.
J Manag Care Spec Pharm; 2018 Jun; 24(6):572-578. PubMed ID: 29799323
[TBL] [Abstract][Full Text] [Related]
14. AMCP Partnership Forum: Preparing for and managing rare diseases.
J Manag Care Spec Pharm; 2021 Mar; 27(3):415-420. PubMed ID: 33538235
[TBL] [Abstract][Full Text] [Related]
15. Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
Hughes-Wilson W; Palma A; Schuurman A; Simoens S
Orphanet J Rare Dis; 2012 Sep; 7():74. PubMed ID: 23013790
[TBL] [Abstract][Full Text] [Related]
16. AMCP Guide to Pharmaceutical Payment Methods.
AMCP Task Force on Drug Payment Methodologies
J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
[TBL] [Abstract][Full Text] [Related]
17. AMCP Partnership Forum: Digital Therapeutics-What Are They and Where Do They Fit in Pharmacy and Medical Benefits?
J Manag Care Spec Pharm; 2020 May; 26(5):674-681. PubMed ID: 32175784
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Specialty Drug Price Trends Using Data from Retrospective Pharmacy Sales Transactions.
Penington R; Stubbings JA
J Manag Care Spec Pharm; 2016 Sep; 22(9):1010-7. PubMed ID: 27574742
[TBL] [Abstract][Full Text] [Related]
19. Orphan drug pricing and payer management in the United States: are we approaching the tipping point?
Hyde R; Dobrovolny D
Am Health Drug Benefits; 2010 Jan; 3(1):15-23. PubMed ID: 25126305
[TBL] [Abstract][Full Text] [Related]
20. AMCP Partnership Forum: Enabling the Exchange of Clinical and Economic Information Pre-FDA Approval.
J Manag Care Spec Pharm; 2017 Jan; 23(1):105-112. PubMed ID: 28025919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
